In a recent clinical letter published by the Brazilian Society of Dermatology, researchers highlight the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in ...

Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.

The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions.

HORSHAM, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...

Q: Which doctor treats mycosis fungoides? A: Mycosis fungoides is treated by a team of doctors which includes a dermatologist and an oncologist. A: In general, mycosis fungoides is considered a ...

Literature review identified the following 10 candidate markers: stage, age, sex, cutaneous histologic features of folliculotropism, CD30 positivity, proliferation index, large-cell transformation, ...

Cutaneous T-cell lymphoma (CTCL) is the term for diseases characterized by primary accumulation of malignant T cells in the skin. Patients with the two predominant clinical forms of CTCL called ...

MALVERN, Pa.--(BUSINESS WIRE)--Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted marketing ...

Please provide your email address to receive an email when new articles are posted on . Cutaneous staging was the only significant predictive variable of disease-specific survival in patients with ...

Hypopigmented mycosis fungoides is an uncommon clinical variant of cutaneous T-cell lymphoma. We hypothesized that hypomelanosis in hypopigmented mycosis fungoides may have a similar mechanism as in ...

The cause of mycosis fungoides is unknown and, with the possible exception of very early stage disease, no cure is available. Fortunately, patients with MF have a number of therapeutic options and ...